All News

The charges involve falsified claims for expensive hepatitis C medications.

Two new biosimilar announcements are expected to increase the uptake of the biosimilar infliximab to Johnson & Johnson’s Remicade for rheumatoid arthritis, Crohn’s disease, and other inflammatory conditions.

Generic drugs produced $227 billion in savings for the U.S. healthcare system in 2015

Mark Gilmore, partial owner of compounding and specialty pharmacy QMedRx in Maitland, Fla., is one of several compounders who have been accused by the government of filing improper claims to the TRICARE program.

One state's pharmacy board is debating that issue.

Omnicare agreed to settle claims that it conspired with Abbott Laboratories “to engage in a number of disguised kickback arrangements to increase overall use of Depakote,”

In today’s healthcare landscape, few things better define the role of a managed healthcare executive than managing the industry’s constant changes.

Understanding the unique challenges that patients with T1D face can help pharmacists better serve this patient population.

NCPA has formed a new company designed to encourage local networks of pharmacies to provide enhanced services. Details here.

There are at least three major areas of concern

A new study suggests that the name of a biosimilar product could influence pharmacist confidence levels when dispensing a biosimilar in place of a reference biologic.

And as with what seems like every area of healthcare, changes and challenges to the vital supply chain have been coming and will continue to come for the foreseeable future.

Many pharmacists support FDA’s recent warning letters to drug stores, smoke shops, and other retailers over selling e-cigarettes, hookah tobacco, and cigars to minors.

Whether you like it or not, your patients are paying attention, and judging all of us.

A recent report projects an 11% to 13% increase in total drug expenditures in hospitals and health systems in 2016.

Managing the costs of specialty pharmaceuticals is a perpetual task for specialty pharmacists.

The Centers for Medicare and Medicaid Services (CMS) has once again released its Physician Fee Schedule Proposed Rule for Calendar Year 2017.

Many smaller organizations rely on the 340B program to continue serving their communities – and they can’t afford penalties for noncompliance.

Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.

If you’re a pharmacist, you’ve undoubtedly heard the question, Are there too many pharmacy schools?

Somewhere in the United States, there may be a retail or specialty pharmacy that is not part of a group purchasing organization (GPO). If there is such a pharmacy, it is very hard to find.

The furor over EpiPen pricing is simply the best publicized of many similar price hikes that have left patients unable to pay.

Trying to enhance medication management across a continuum of care in a multi-facility hospital IT environment is no easy task.

The retail chain has linked itself with EnvisionRx.

While FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs.

Generic drugmakers and others are pushing for faster FDA approval of generics.

The profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.

In patients with COPD who have a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with fewer exacerbations than usual care without a greater risk of serious adverse events

Patients with severe COPD are likely to suffer frequent disease exacerbations and a reduced quality of life.